Research Frontiers receives Nasdaq deficiency notices for bid price and market value
Research Frontiers Incorporated received two deficiency notification letters from Nasdaq on June 2, 2026, stating the company failed to meet the $1.00 minimum bid price requirement and the $35 million minimum Market Value of Listed Securities requirement for continued listing on The Nasdaq Capital Market. The company has 180 calendar days until November 30, 2026, to regain compliance with both requirements; trading of its common stock under ticker REFR will continue during the compliance period.
Key facts
- Deficiency notices received June 2, 2026
- Failed $1.00 minimum bid price requirement (measured April 15–June 1, 2026)
- Failed $35 million minimum MVLS requirement (measured April 20–June 1, 2026)
- Also does not meet alternative standards for stockholders equity and net income from continuing operations
- 180-calendar-day compliance period through November 30, 2026
- Must achieve $1.00+ closing bid for 10 consecutive business days to regain bid price compliance
- Must achieve $35 million+ MVLS for 10 consecutive business days to regain MVLS compliance
- No reverse stock split currently intended
Why it matters
Failure to regain compliance within the 180-day period could result in delisting from The Nasdaq Capital Market, materially affecting the company's market access and trading liquidity.
Get the next chapter in your inbox — a Sentinel watches this company and briefs the next material filing the moment it lands.
Derived from 8-K filed June 5, 2026. Not investment advice. View the source filing on SEC.gov →